Bioceramics Market
Bioceramics Market Share & Trends Analysis, By Application (Bioceramics for Orthopedic Implants, Bioceramics for Dental Implants, Implantable Electronic Devices), By Material (Alumina Bioceramics, Zirconia Bioceramics, Carbon Bioceramics) & By Region - Global Insights to 2031
Analysis of Bioceramics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Bioceramics
According to the bioceramics market insights gathered by Fact.MR, the global market was valued at over US$ 14 Bn in 2020, and is projected to expand 1.5X over the decade to be valued at US$ 23 Bn by 2031. Amedica Corporation, CeramTec GmbH, CoorsTek Medical LLC and DePuy Synthes are identified as some prominent manufacturers of bioceramics, as per industry analysis.
Key Points Addressed in Bioceramics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Bioceramics and How to Navigate
- Recommendation on Key Winning Strategies
Bioceramics Industry Analysis from 2016-2020 Vs Future Demand Outlook for 2021-2031
Bioceramics market insights reveal a growth trajectory of around 6% CAGR from 2016 to 2020. Demand was largely spurred by continued advancements in biological implants for various surgical procedures, including orthopedic and dental.
Adjusting for COVID-19-induced recessionary pressures, the market for bioceramics was estimated at over US$ 14 Bn in 2020, and is forecast to top US$ 23 Bn by 2031, expanding at a CAGR exceeding 7%. Bioceramics sales forecasts are especially high across the U.S. and Chinese landscapes, given the fast-paced technological advancements in medical implants.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How is Increasing Emphasis on Dental Care Spearheading Bioceramics Adoption?
According to W.H.O, oral diseases pose a major health burden for many countries, with nearly 3.5 Bn patients. These include dental caries, oro-dental trauma, oral cancer, and periodontal (gum) disease, among others. Consequently, spending on dental care has augmented significantly.
Therefore, dentists are leveraging highly advanced implant solutions to prevent teeth loss amongst patients suffering from such conditions. Hence, the popularity of bioceramics is surging rapidly. As they are non-toxic and bioinert, bioceramics implants are the preferred implant choices amongst dental practitioners.
Will Rising Prevalence of Musculoskeletal Disorders Heighten Bioceramics Implants Uptake?
Approximately 1.71 Bn people globally suffer from musculoskeletal conditions, significantly limiting mobility and dexterity, prompting early retirement from work, lower levels of well-being, and reduced ability to participate in society, concludes W.H.O.
As the global population expands, musculoskeletal disorders are multiplying, with conditions such as osteoporosis, osteoarthritis, rheumatoid arthritis and back & neck pain becoming common.
Hence, medical practitioners are experimenting with orthopedic implants, incorporating lightweight and flexible material to reduce discomfort amongst patients, broadening bioceramics demand outlook.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Will Brittle Nature of Key Materials Impede Future Sales of Bioceramics?
Although bioceramics are endowed with significant advantageous properties, including lightweight material composition and enhanced patient comfort, there are several drawbacks that are likely to impede market growth prospects in the long-run forecast period.
For instance, a common drawback to all calcium phosphate bioceramics produced in a porous form is their low mechanical properties, such as brittleness and low fatigue strength. Consequently, such fragility may create problems in patients, as they may need to visit their surgeons more often to get the implant replaced.
Country-wise Analysis
How will Bioceramics Demand Outlook Shape Up in the U.S.?
Analysis of bioceramics sales across North America reveals that, the U.S. generated bulk of total demand, being valued at over US$ 4 Bn in 2020. Extensive consumption across key medical domains is bolstering the growth prospects for this region over the coming years.
According to the American Ceramic Society, bioceramics applications have surged across orthopedics, tissue engineering and dentistry. For hard or soft tissue replacement, bioceramics manufactured from calcium oxide, sodium oxide and phosphorous pentoxide are widely used, while hydroxyapatite coatings are commonly used for ceramic bearings on orthopedic implants.
What are the Growth Opportunities for Bioceramics across China?
China is forecast to reach a projected market size of US$ 4 Bn by 2031, expanding at a CAGR of over 6%. Bioceramics demand outlook across the East Asian giant is attributed to extensive spending to augment healthcare infrastructure. Further impetus is being provided by the Made in China 2025 campaign.
Estimates suggest that China spends 6% of its GDP on healthcare, with its medical device market experiencing double digit growth since the past three decades.
Advancements in orthopedic and dental surgeries have yielded fertile opportunities for various bioceramics manufacturers in the recent past, as practitioners seek to incorporate lightweight yet robust implant materials.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Category-wise Insights
Why are Carbon Bioceramics Acquiring Popularity?
By product, sales of carbon bioceramics are anticipated to surge at a CAGR of over 7% until 2031, attributed to their high density and enhanced fiber strength. Moreover, their light weight offers convenience to patients as well as surgeons in terms of implant positioning.
Vitreous carbon is also used as it is light, resistant to wear, and compatible with blood. It is mostly used in cardiac valve replacement. Diamond can be used for the same application, but in coating form.
Will Bioceramics Usage be Maximum for Dental Implant Manufacturing?
As per Fact.MR’s bioceramics market insights, demand for dental implants generated over 40% of the total revenue until 2020. Increasing demand for ceramic-based crowns and bridges owing to close resemblance to original teeth are majorly driving growth in this segment.
Simultaneously, growth across the orthopedic segment is also expected to incline, registering a CAGR of approximately 6% until 2031. Rising incorporation of key materials such as zirconium, aluminum and hydroxyapatite to reduce chances of dislocation shall drive growth in this segment.
Competitive Landscape
The global market for bioceramics is characterized by the presence of limited manufacturers, offering specialized product offerings for multiple end users. Players are largely involved in forging collaborations and acquisitions, among other expansion strategies, to leverage existing growth prospects.
- In October 2020, Amedica Corporation secured a patent from the U.S Patent & Trademark Office for articulating intervertebral devices, related tools, systems and methods to address challenges associated with traditional transforaminal lumbar interbody fusion (TLIF) procedures.
- In April 2021, CoorsTek announced an additional expansion of its manufacturing footprint in Benton, Arkansas, so as to support the evolution and innovation in key domains, including bioceramics.
- In June 2021, Morgan Advanced Materials Plc. was awarded with the AAA rating for its sustainability achievements and initiatives by MSCI, as the company accelerates its environmental, social and governance (ESG) credentials program, including manufacturing bioceramics.
Report Scope
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2016-2020 |
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing |
Available upon Request |
Key Segments
-
Application
- Bioceramics for Orthopedic Implants
- Bioceramics for Dental Implants
- Bioceramics for Implantable Electronic Devices
- Bioceramics for Other Applications
-
Material
- Alumina Bioceramics
- Zirconia Bioceramics
- Carbon Bioceramics
- Other Material Bioceramics
- FAQs -
The global bioceramics market is valued at above US$ 14 Bn.
Demand for bioceramics to top US$ 23 Bn by 2031, expanding nearly 1.5X.
From 2016 to 2020, sales of bioceramics applications increased at a CAGR of approximately 6%.
Sales of bioceramics around the world are largely expected to be driven by surging applications across dental and orthopedic implants.
The U.S., Canada, Japan, China, and Germany are the top 5 markets expected to grow at nearly 8% CAGRs, especially in the carbon bioceramics domain.
North America is expected to generate significant expansion opportunities, where the U.S. contributed over US$ 4 Bn market value in 2020.
Sales of bioceramics across Europe are expected to account for over 2/5 of global revenue across the 2021-2031 assessment period.
Orthopedic implants and dental implants are expected to collectively yield over 50% revenue in the long run.
Amedica Corporation, CeramTec GmbH, CoorsTek Medical LLC, and DePuy Synthes are prominent players manufacturing bioceramics across key regions.
The Asia Pacific bioceramics landscape is expected to yield almost US$ 3 Bn by 2031.